Novo Nordisk A/S (NYSE:NVO) shares are moving higher on Thursday. Hims & Hers Health Inc (NYSE:HIMS) announced it will begin offering several of the Novo’s FDA‑approved GLP‑1 medications, including the newly launched Wegovy pill.
Importance Rank:
1